SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
245 hedge funds and large institutions have $6.31B invested in SALIX PHARMACEUTICALS LTD DEL in 2013 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 83 increasing their positions, 107 reducing their positions, and 36 closing their positions.
127% more call options, than puts
Call options by funds: $83.6M | Put options by funds: $36.8M
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
57% more capital invested
Capital invested by funds: $4.01B → $6.31B (+$2.3B)
2% less funds holding
Funds holding: 251 → 245 (-6)
14% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 36
22% less repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 107
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$453M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$82.4M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
+$65.9M |
| 4 |
VAM
Visium Asset Management
New York
|
+$39.1M |
| 5 |
HM
HealthCor Management
New York
|
+$31.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$135M |
| 2 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$92.3M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$62.4M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$58.2M |
| 5 |
PC
PointState Capital
New York
|
-$35.4M |
SLXP Hedge Fund Activity: Q4 2013 in Review
245 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q4 2013, worth a combined $6.31B — up 57% from $4.01B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of SLXP and 31 opened new positions — a net loss of 5 holders — while 107 trimmed existing stakes and 83 added.
The largest buyer was Fidelity Investments, adding an estimated $453M. The largest seller was Bank of America, cutting an estimated $135M.
- 245 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q4 2013, down from 251 in Q3 2013.
- Funds reported $6.31B of SALIX PHARMACEUTICALS LTD DEL stock for Q4 2013, up 57% quarter-over-quarter.
- 31 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q4 2013 and 36 closed out, a net change of -5 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q4 2013 was Fidelity Investments, an estimated $453M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q4 2013 was Bank of America, an estimated $135M sold.
Based on aggregated 13F filings for Q4 2013.